End-of-day quote
Korea S.E.
06:00:00 2024-04-29 pm EDT
|
5-day change
|
1st Jan Change
|
1,752
KRW
|
+0.11%
|
|
+2.88%
|
-32.62%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
86,541
|
76,984
|
61,941
|
113,972
|
71,675
|
92,027
|
Enterprise Value (EV)
1 |
144,575
|
80,443
|
53,488
|
102,237
|
55,489
|
73,503
|
P/E ratio
|
-23.3
x
|
20.1
x
|
20.1
x
|
10.8
x
|
16.7
x
|
18.6
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
0.37
x
|
0.38
x
|
0.32
x
|
0.44
x
|
0.29
x
|
0.38
x
|
EV / Revenue
|
0.62
x
|
0.39
x
|
0.27
x
|
0.4
x
|
0.23
x
|
0.3
x
|
EV / EBITDA
|
201
x
|
42.1
x
|
9.93
x
|
6.51
x
|
9.57
x
|
10.4
x
|
EV / FCF
|
-33.2
x
|
-28.6
x
|
4.28
x
|
122
x
|
15.4
x
|
-344
x
|
FCF Yield
|
-3.01%
|
-3.5%
|
23.4%
|
0.82%
|
6.47%
|
-0.29%
|
Price to Book
|
1.15
x
|
0.96
x
|
0.74
x
|
1.2
x
|
0.72
x
|
0.88
x
|
Nbr of stocks (in thousands)
|
35,395
|
35,395
|
35,395
|
35,395
|
35,395
|
35,395
|
Reference price
2 |
2,445
|
2,175
|
1,750
|
3,220
|
2,025
|
2,600
|
Announcement Date
|
3/13/19
|
3/16/20
|
3/16/21
|
3/16/22
|
3/20/23
|
3/18/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
231,807
|
203,876
|
195,418
|
258,382
|
245,980
|
244,376
|
EBITDA
1 |
718.7
|
1,912
|
5,384
|
15,708
|
5,796
|
7,044
|
EBIT
1 |
-1,736
|
-1,835
|
3,404
|
13,966
|
4,255
|
5,601
|
Operating Margin
|
-0.75%
|
-0.9%
|
1.74%
|
5.41%
|
1.73%
|
2.29%
|
Earnings before Tax (EBT)
1 |
-3,988
|
5,890
|
3,094
|
13,154
|
5,456
|
6,515
|
Net income
1 |
-3,721
|
3,840
|
3,080
|
10,523
|
4,297
|
4,952
|
Net margin
|
-1.61%
|
1.88%
|
1.58%
|
4.07%
|
1.75%
|
2.03%
|
EPS
2 |
-105.1
|
108.0
|
87.00
|
297.0
|
121.0
|
139.9
|
Free Cash Flow
1 |
-4,349
|
-2,816
|
12,498
|
839.6
|
3,592
|
-213.7
|
FCF margin
|
-1.88%
|
-1.38%
|
6.4%
|
0.32%
|
1.46%
|
-0.09%
|
FCF Conversion (EBITDA)
|
-
|
-
|
232.12%
|
5.34%
|
61.98%
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
405.76%
|
7.98%
|
83.61%
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
3/13/19
|
3/16/20
|
3/16/21
|
3/16/22
|
3/20/23
|
3/18/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
58,034
|
3,459
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
-
|
-
|
8,453
|
11,735
|
16,186
|
18,525
|
Leverage (Debt/EBITDA)
|
80.75
x
|
1.809
x
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-4,349
|
-2,816
|
12,498
|
840
|
3,592
|
-214
|
ROE (net income / shareholders' equity)
|
-4.87%
|
4.94%
|
3.75%
|
11.8%
|
4.42%
|
4.86%
|
ROA (Net income/ Total Assets)
|
-0.71%
|
-0.78%
|
1.58%
|
6.37%
|
1.87%
|
2.53%
|
Assets
1 |
525,934
|
-493,018
|
195,262
|
165,265
|
229,503
|
195,446
|
Book Value Per Share
2 |
2,118
|
2,276
|
2,371
|
2,677
|
2,811
|
2,944
|
Cash Flow per Share
2 |
74.20
|
1,078
|
907.0
|
1,075
|
792.0
|
868.0
|
Capex
1 |
8,065
|
2,512
|
601
|
1,142
|
753
|
1,065
|
Capex / Sales
|
3.48%
|
1.23%
|
0.31%
|
0.44%
|
0.31%
|
0.44%
|
Announcement Date
|
3/13/19
|
3/16/20
|
3/16/21
|
3/16/22
|
3/20/23
|
3/18/24
|
|
1st Jan change
|
Capi.
|
---|
| -32.62% | 45.03M | | +4.41% | 103B | | +1.20% | 68.41B | | +44.29% | 39.97B | | +15.99% | 38.97B | | +5.14% | 33.12B | | +5.29% | 19.41B | | +12.32% | 16.73B | | +8.31% | 15.34B | | +17.69% | 15.07B |
Other Commodity Chemicals
|